Adrenaline for the Treatment of No-Reflow in Normotensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT04699110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 201 participants
- Registry
-
NCT04699110
-
- Other papers using this trial's data
- Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT04699110. Randomized; no masking; primary purpose treatment. Start 2021-01-01 (actual); primary completion 2021-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adrenaline for the Treatment of No-Reflow in Normotensive Patients
- Condition
- Acute Coronary Syndrome
- Condition
- No-Reflow Phenomenon
- Condition
- Normotensive
- Intervention (Drug)
- Adrenaline
- Intervention (Drug)
- Adenosine
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct04699110- Content hash
29fd885329691325e4bce86c729622e2e974978dd8d7a83c4031cddfa45b2af9